Mr. Wiest joins the InCarda CMC team with 13 years of experience in formulation and process development for pharmaceutical drug products. He has expertise in developing solid oral and sterile liquids for inhalation for drug product programs ranging from pre-clinical to validation and commercialization. Prior to InCarda, Brian was a scientist at Ardelyx where he was the lead formulator for a novel therapy blocking absorption of phosphate in the GI tract to treat hyperphosphatemia. Before Ardelyx, Brian worked at Gilead Sciences for 11 years in various formulation roles of increasing responsibility.
Brian earned his BS in Chemistry from Gonzaga University and Masters in Applied Statistics from Pennsylvania State University.